The estimated Net Worth of John Mc Ilwraith is at least $684 mil dollars as of 25 February 2020. Mr. Ilwraith owns over 5,000 units of Meridian Bioscience stock worth over $583,163 and over the last 9 years he sold VIVO stock worth over $0. In addition, he makes $101,000 as Independent Director at Meridian Bioscience.
John has made over 6 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVO stock worth $37,950 on 25 February 2020.
The largest trade he's ever made was buying 5,000 units of Meridian Bioscience stock on 25 February 2020 worth over $37,950. On average, John trades about 750 units every 98 days since 2015. As of 25 February 2020 he still owns at least 17,167 units of Meridian Bioscience stock.
You can see the complete history of Mr. Ilwraith stock trades at the bottom of the page.
John C. McIlwraith J.D. serves as Independent Director of the Company. Prior to founding Allos Ventures, Mr. McIlwraith was a Managing Director of Blue Chip Venture Company, a Cincinnati-based venture capital firm, which he joined in 1997. He has served on the board of directors of more than 20 health care or information technology companies. Prior to 1997, Mr. McIlwraith served as Senior Vice President of Strategic Planning and General Counsel of publicly-traded Quantum Health Resources, Inc., and was a partner in the Jones Day law firm. The Board believes that Mr. McIlwraith’s corporate legal and business development experience, and his years of business-building experience with an extensive number of companies, including health care companies, render his service on the Board valuable to Meridian.
As the Independent Director of Meridian Bioscience, the total compensation of John McIlwraith at Meridian Bioscience is $101,000. There are 12 executives at Meridian Bioscience getting paid more, with John P. Kenny having the highest compensation of $1,508,705.
John McIlwraith is 60, he's been the Independent Director of Meridian Bioscience since 2015. There are 5 older and 8 younger executives at Meridian Bioscience. The oldest executive at Meridian Bioscience Inc. is David Phillips, 81, who is the Independent Chairman of the Board.
John's mailing address filed with the SEC is 3471 RIVER HILLS DRIVE, , CINCINNATI, OH, 45244.
Over the last 22 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny y John A Kraeutler. On average, Meridian Bioscience executives and independent directors trade stock every 41 days with the average trade being worth of $424,761. The most recent stock trade was executed by James M. Anderson on 6 January 2023, trading 8,500 units of VIVO stock currently worth $173,230.
Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.
Meridian Bioscience executives and other stock owners filed with the SEC include: